These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 8510008

  • 1. Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines.
    Nelson DL, Lucaites VL, Audia JE, Nissen JS, Wainscott DB.
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1272-9. PubMed ID: 8510008
    [Abstract] [Full Text] [Related]

  • 2. N(1)-substituted ergolines and tryptamines show species differences for the agonist-labeled 5-HT2 receptor.
    Johnson MP, Audia JE, Nissen JS, Nelson DL.
    Eur J Pharmacol; 1993 Aug 03; 239(1-3):111-8. PubMed ID: 8223886
    [Abstract] [Full Text] [Related]

  • 3. Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
    Johnson MP, Loncharich RJ, Baez M, Nelson DL.
    Mol Pharmacol; 1994 Feb 03; 45(2):277-86. PubMed ID: 8114677
    [Abstract] [Full Text] [Related]

  • 4. Studies with new ergoline derivatives on the effects of central and peripheral 5-hydroxytryptamine receptors.
    Harhammer R, Schäfer U, Ott T.
    Arzneimittelforschung; 1992 Oct 03; 42(10):1175-9. PubMed ID: 1472137
    [Abstract] [Full Text] [Related]

  • 5. [3H]ketanserin labels serotonin 5-HT2 and alpha 1-adrenergic receptors in human brain cortex.
    Hoyer D, Vos P, Closse A, Palacios JM, Engel G, Davies H.
    J Cardiovasc Pharmacol; 1987 Oct 03; 10 Suppl 3():S48-50. PubMed ID: 2446070
    [Abstract] [Full Text] [Related]

  • 6. 5-Hydroxytryptamine2 receptor antagonist activity of the acid metabolite (1-isopropyl dihydrolysergic acid) of the ergoline ester, sergolexole (LY281067).
    Cohen ML, Parli CJ, Fuller RW.
    J Pharmacol Exp Ther; 1989 Dec 03; 251(3):1006-11. PubMed ID: 2600800
    [Abstract] [Full Text] [Related]

  • 7. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
    Branchek T, Adham N, Macchi M, Kao HT, Hartig PR.
    Mol Pharmacol; 1990 Nov 03; 38(5):604-9. PubMed ID: 2233697
    [Abstract] [Full Text] [Related]

  • 8. Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, and elymoclavine as partial agonists and antagonists at rat 5-HT2A receptors: pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high 5-HT2A receptor affinity.
    Pertz HH, Milhahn H, Eich E.
    J Med Chem; 1999 Feb 25; 42(4):659-68. PubMed ID: 10052973
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological activity of the isomers of LY53857, potent and selective 5-HT2 receptor antagonists.
    Cohen ML, Kurz KD, Mason NR, Fuller RW, Marzoni GP, Garbrecht WL.
    J Pharmacol Exp Ther; 1985 Nov 25; 235(2):319-23. PubMed ID: 4057073
    [Abstract] [Full Text] [Related]

  • 10. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
    Almaula N, Ebersole BJ, Ballesteros JA, Weinstein H, Sealfon SC.
    Mol Pharmacol; 1996 Jul 25; 50(1):34-42. PubMed ID: 8700116
    [Abstract] [Full Text] [Related]

  • 11. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
    Monte AP, Marona-Lewicka D, Lewis MM, Mailman RB, Wainscott DB, Nelson DL, Nichols DE.
    J Med Chem; 1998 Jun 04; 41(12):2134-45. PubMed ID: 9622555
    [Abstract] [Full Text] [Related]

  • 12. Comparison of two different arterial tissues suggests possible 5-hydroxytryptamine2 receptor heterogeneity.
    Killam AL, Nikam SS, Lambert GM, Martin AR, Nelson DL.
    J Pharmacol Exp Ther; 1990 Mar 04; 252(3):1083-9. PubMed ID: 2319460
    [Abstract] [Full Text] [Related]

  • 13. Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine2 and 5-hydroxytryptamine1c serotonin receptors.
    Choudhary MS, Craigo S, Roth BL.
    Mol Pharmacol; 1992 Oct 04; 42(4):627-33. PubMed ID: 1435740
    [Abstract] [Full Text] [Related]

  • 14. Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding.
    Choudhary MS, Sachs N, Uluer A, Glennon RA, Westkaemper RB, Roth BL.
    Mol Pharmacol; 1995 Mar 04; 47(3):450-7. PubMed ID: 7700242
    [Abstract] [Full Text] [Related]

  • 15. [3H]ketanserin labels 5-HT2 receptors and alpha 1-adrenoceptors in human and pig brain membranes.
    Hoyer D, Vos P, Closse A, Pazos A, Palacios JM, Davies H.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar 04; 335(3):226-30. PubMed ID: 2884572
    [Abstract] [Full Text] [Related]

  • 16. Interaction of tryptamine and ergoline compounds with threonine 196 in the ligand binding site of the 5-hydroxytryptamine6 receptor.
    Boess FG, Monsma FJ, Meyer V, Zwingelstein C, Sleight AJ.
    Mol Pharmacol; 1997 Sep 04; 52(3):515-23. PubMed ID: 9284367
    [Abstract] [Full Text] [Related]

  • 17. Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors.
    Pazos A, Hoyer D, Palacios JM.
    Eur J Pharmacol; 1984 Nov 27; 106(3):531-8. PubMed ID: 6519174
    [Abstract] [Full Text] [Related]

  • 18. 3-H-ketanserin (serotonin type 2) binding in the rat frontal cortex: effect of immobilization stress.
    Torda T, Culman J, Cechová E, Murgas K.
    Endocrinol Exp; 1988 Jun 27; 22(2):99-105. PubMed ID: 3261685
    [Abstract] [Full Text] [Related]

  • 19. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
    Leysen JE, Gommeren W, Heylen L, Luyten WH, Van de Weyer I, Vanhoenacker P, Haegeman G, Schotte A, Van Gompel P, Wouters R, Lesage AS.
    Mol Pharmacol; 1996 Dec 27; 50(6):1567-80. PubMed ID: 8967979
    [Abstract] [Full Text] [Related]

  • 20. Preclinical studies on LY237733, a potent and selective serotonergic antagonist.
    Foreman MM, Fuller RW, Nelson DL, Calligaro DO, Kurz KD, Misner JW, Garbrecht WL, Parli CJ.
    J Pharmacol Exp Ther; 1992 Jan 27; 260(1):51-7. PubMed ID: 1731051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.